Track topics on Twitter Track topics that are important to you
Luisa Stamm has joined Assembly Biosciences (NASDAQ: ASMB) as chief medical officer. Stamm comes to South San Francisco-based Assembly from Gilead Siences (NASDAQ: GILD), where she was executive director in the liver diseases therapeutic area, as well as executive director in the HIV and emerging viruses therapeutic area. Assembly is developing drugs for hepatitis B […]
Original Article: Gilead’s Luisa Stamm Named Assembly Biosciences Chief Medical OfficerNEXT ARTICLE
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...